Novo Holdings Glaukos Corp Transaction History

Novo Holdings

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $17.6 Million - $25.2 Million	-300,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $19.4 Million - $24 Million	-305,266 Reduced 50.44%	300,000 $22.6 Million
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $133,424 - $173,697	2,557 Added 0.42%	605,266 $34 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $1.04 Million - $1.67 Million	37,544 Added 6.64%	602,709 $24.5 Million
Q1 2018 May 15, 2018	BUY	$26.05 - $34.5 $10.6 Million - $14.1 Million	408,736 Added 261.29%	565,165 $17.4 Million
Q4 2017 Feb 14, 2018	BUY	$24.5 - $36.01 $3.83 Million - $5.63 Million	156,429	156,429 $4.01 Million

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.2B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.